Additionally, both the analysis of our cases and a review of previously reported cases show that ALK + DLBCL can be an aggressive malignancy that can be cured with conventional chemotherapy protocols only at the stage of localized disease [19]. This evidence concerns the gene ALK and diffuse large B-cell lymphoma.